Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Mar 28, 2005; 11(12): 1854-1858
Published online Mar 28, 2005. doi: 10.3748/wjg.v11.i12.1854
Published online Mar 28, 2005. doi: 10.3748/wjg.v11.i12.1854
Table 4 Serum concentrations of GF in virological responders and non-responders, Student’s t test (mean±SD).
| Growth factor | Responders | Non-responders | P | |||
| 0 wk | 48 wk | 0 wk | 48 wk | 0 wk | 48 wk | |
| HGF (pg/mL) | 873±210 | 792±198 | 919±257 | 742±260 | 0.6 | 0.7 |
| EGF (pg/mL) | 16.8±5.8 | 16.1±6.2 | 20.4±8.4 | 15.5±4.9 | 0.2 | 0.8 |
| TPO (pg/mL) | 48.4±14 | 68.8±13 | 64.2±17.1 | 54.8±12 | 0.03 | 0.2 |
| PDGF (pg/mL) | 425±111 | 292±180 | 340±111 | 377±98 | 0.1 | 0.1 |
- Citation: Anatol P, Robert F, Danuta P. Effect of interferon alpha2b plus ribavirin treatment on selected growth factors in respect to inflammation and fibrosis in chronic hepatitis C. World J Gastroenterol 2005; 11(12): 1854-1858
- URL: https://www.wjgnet.com/1007-9327/full/v11/i12/1854.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i12.1854